Work

Response and oligoclonal resistance to pembrolizumab in uterine leiomyosarcoma: Genomic, neoantigen, and immunohistochemical evaluation.

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.11043

Authors: Diana Miao, Dennis Adeegbe, Scott J. Rodig, Sachet Shukla, Ali Amin-Mansour, Scott L. Carter, Catherine Wu, Kwok-Kin Wong, Chandrajit P. Raut, Patrick Alexander Ott, Eliezer Mendel Van Allen, George D. Demetri, Suzanne George

Institutions: Broad Institute, Dana-Farber Cancer Institute, Brigham and Women's Hospital, Harvard University, Dana-Farber/Harvard Cancer Center, Dana-Farber Brigham Cancer Center

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2745426468

Cites:

Cited by: 5

Related to: 10